Human recombinant alkaline phosphatase: a promising, yet-to-be-tested agent for the treatment sepsis-induced acute kidney injury
- PMID: 30740445
- PMCID: PMC6330598
- DOI: 10.21037/atm.2018.12.17
Human recombinant alkaline phosphatase: a promising, yet-to-be-tested agent for the treatment sepsis-induced acute kidney injury
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Comment on
-
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.JAMA. 2018 Nov 20;320(19):1998-2009. doi: 10.1001/jama.2018.14283. JAMA. 2018. PMID: 30357272 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources